Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$6.50
+7.08%
Mkt Cap $654.23M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+161.5%
Consensus $17.00 vs current $6.50
NASDAQ·Healthcare·Biotechnology
$6.50
+7.08%
Mkt Cap $654.23M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+161.5%
Consensus $17.00 vs current $6.50